NCT03678883 2024-11-079-ING-41 in Patients with Advanced CancersActuate Therapeutics Inc.Phase 2 Active not recruiting350 enrolled
NCT05189483 2024-02-07Albumin-bound Paclitaxel Plus Camrelizumab for Advanced Soft Tissue Sarcoma.Henan Cancer HospitalPhase 2 Unknown40 enrolled